Not Medicare Enrolled

Dr. Jeffrey Benzick, MD

Psychiatry · San Antonio, TX
Low-engagement
12915 JONES MALTSBERGER RD, San Antonio, TX 78247
2104032050
In practice since 2006 (19 years)
NPI: 1447295316 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Benzick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benzick? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Benzick

Dr. Jeffrey Benzick is a psychiatry specialist in San Antonio, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Benzick received a total of $12,005 from 35 pharmaceutical and/or device companies across 671 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Benzick is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $12,005 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,005
Total received (2018-2024)
Avg $1,715/year across 7 years
Top 6% in TX for psychiatry
35
Companies
671
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,005 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,324
2023
$2,035
2022
$1,702
2021
$1,924
2020
$1,568
2019
$1,586
2018
$866

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lundbeck LLC
$1,380
Otsuka America Pharmaceutical, Inc.
$1,330
Takeda Pharmaceuticals U.S.A., Inc.
$1,074
Janssen Pharmaceuticals, Inc
$825
Alkermes, Inc.
$705
AbbVie Inc.
$654
ITI, Inc.
$630
Ironshore Pharmaceuticals Inc.
$615
Allergan, Inc.
$541
ABBVIE INC.
$524
Sunovion Pharmaceuticals Inc.
$506
Axsome Therapeutics, Inc.
$469
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$402
Neos Therapeutics, LP
$287
Vanda Pharmaceuticals Inc.
$266
Corium, LLC
$223
Allergan Inc.
$212
Shire North American Group Inc
$135
ARBOR PHARMACEUTICALS, INC.
$132
Supernus Pharmaceuticals, Inc.
$124
Avanir Pharmaceuticals, Inc.
$112
Adlon Therapeutics L.P.
$102
Eisai Inc.
$94
Teva Pharmaceuticals USA, Inc.
$92
Tris Pharma Inc
$83
Noven Therapeutics, LLC
$79
Bausch Health US, LLC
$77
IRONSHORE PHARMACEUTICALS INC.
$68
Merck Sharp & Dohme Corporation
$51
Rhodes Pharmaceuticals L.P.
$49
JAZZ PHARMACEUTICALS INC.
$48
Vertical Pharmaceuticals, LLC
$47
Neuronetics, Inc.
$27
Almatica Pharma LLC
$27
IDORSIA PHARMACEUTICALS US INC
$15
Top 3 companies account for 31.5% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Cotempla XR-ODT · Dayvigo · Dyanavel XR · Edarbi · Evekeo · Fanapt · GRALISE · HETLIOZ · Horizant · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUNOSI · Secuado · Sunosi · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for psychiatry in TX.

Looking for a psychiatry specialist in San Antonio?
Compare psychiatrists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
330
Per 100K population
16.2
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
3.1 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Benzick is a psychiatry specialist, with low-engagement industry engagement in the top 6% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Benzick receive payments from pharmaceutical companies?
Yes. Dr. Benzick received a total of $12,005 from 35 companies across 671 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Benzick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in San Antonio
Browse psychiatrists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →